Costa Rica is home to 500,000 species of plants and animals that are unique to that country. Many times human actions such as rainforest destruction result in the loss of many unique species. For almost thirty years, the government of Costa Rica has worked with medical, pharmaceutical, agricultural, biotechnology, and food industries in what has been called biodiversity prospecting.
The National Biodiversity Institute of Costa Rica (INBio) was established in 1989. In 1991 they reached an agreement with the pharmaceutical giant Merck to explore the forests of Costa Rica to find marketable drugs from the resources there. Merck paid money up-front and agreed to pay royalties on any drugs they discovered. Instead of destroying the diversity of wildlife, bio-prospecting encourages sustainable use. Similar efforts could be made in other nations that still have unexplored regions both in forests and in ocean ecological systems.
We would suggest that one of the things God has done is to build into the world’s ecology materials that humans can use to promote their well being. These natural materials are much more likely to produce solutions without ecological drawbacks than human-made synthetics. The Bible refers to materials that ancient people used to serve various purposes. Genesis 30:14-16 is an example where the Hebrew word dudai is translated “mandrakes” and is also found in Song of Solomon 7:13. Another example is what the Hebrew rimmon translated “pomegranate” in Deuteronomy 8:8. In ancient times, people used it to make astringent medicines.
Biologists are still learning what ancient people knew, and what some primitive tribes in today’s world know about natural medicines. God has already created many solutions to what ails us, but they await our discovery. If biodiversity prospecting can bring financial resources to developing countries while sustaining their natural habitats and creatures, we believe that is good stewardship of God’s gifts.
— John N. Clayton © 2020
Original article in Wildlife Digest, December 1991, page 29. For further information click HERE and HERE.